The guideline, Prevention of Perinatal Group B Streptococcal Disease, was developed by the Centers for Disease Control and Prevention and was endorsed with qualifications by the American Academy of Family Physicians in 2010. The endorsement process has since been modified and the guideline was re-reviewed and categorized as Affirmation of Value.
Access article with full recommendations for more information on prevention of perinatal Group B streptococcal disease, including recommendations for women undergoing cesarean delivery, NAAT site-of-care testing, algorithm for threatened preterm delivery, and algorithm for newborn management.
These guidelines are provided only as assistance for physicians making clinical decisions regarding the care of their patients. As such, they cannot substitute the individual judgment brought to each clinical situation by the patient’s family physician. As with all clinical reference resources, they reflect the best understanding of the science of medicine at the time of publication, but they should be used with the clear understanding that continued research may result in new knowledge and recommendations. These guidelines are only one element in the complex process of improving the health of America. To be effective, the guidelines must be implemented.
For Your Patients
Download the Group B Strep (GBS) Prevention app(itunes.apple.com), developed by the Centers for Disease Control and Prevention in collaboration with the AAFP and several other medical associations.
Share this page
Alert: Message field is required.
You must sign in before you can share a page on AAFP connection.
Group B Strep - Clinical Practice Guideline